liposomatechnology 品牌介绍
品牌简介
Asha van Rooijen于2013年创立LIPOSOMA，将免疫研究的研究工具氯膦酸盐脂质体推向市场。氯膦酸盐脂质体由Nico van Rooijen开发，在世界范围内用于研究各种自身免疫疾病、移植、神经系统疾病和基因治疗模型。Asha和她的团队将收入的绝大部分投资于研发，扩大了LIPOSOMA在从免疫学研究到维生素补充剂和医疗营养等广泛行业的业务。LIPOSOMA的使命是成为世界领先的脂质纳米颗粒公司，这是由其对科学卓越的承诺所保证的。目前LIPOSOMA作为CMO和品牌标签提供商提供脂质体和其他基于脂质的产品，为广泛的人类健康产品提供平台技术。
Asha van Rooijen founded LIPOSOMA in 2013 to bring Clodronate Liposomes, a research tool for immunological research, to the market. Clodronate Liposomes were developed by Nico van Rooijen and are used worldwide to study various models of autoimmune diseases, transplantation, neurological disorders and gene therapy. By investing an overwhelming share of revenues in research & development, Asha and her team expanded LIPOSOMA’s activities in a wide range of industries, ranging from immunological research to vitamin supplements and medical nutrition. It is LIPOSOMA’s mission to be a world leading lipid nanoparticle based company, guaranteed by its commitment to scientific excellence. Currently LIPOSOMA provides liposomal and other lipid based products as a CMO and branded label provider, offering platform technology for a wide range of human health products.
main products
LIPOSOMES
https://www.liposomatechnology.com
联系我们
